Dose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III & Grade IV Gliomas
Clinical trial NCT00031083 · COMPLETED
Trial details
- NCT number
- NCT00031083
- Sponsor
- Biogen
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2002-04-02
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.